Mavorixafor trihydrochloride
Mavorixafor trihydrochloride is a potent, orally bioavailable CXCR4 antagonist with an IC50 of 13 nM. It inhibits T-tropic HIV-1 replication in vitro (IC50s: 1-9 nM) and is a key research tool for studying CXCR4's role in cancer metastasis, WHIM syndrome, and stem cell mobilization.
Product Specifications
CAS Number
2309699-17-8
Field of Research
Cell Biology, Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Smiles
Cl.Cl.Cl.NCCCCN (Cc1nc2ccccc2[nH]1) [C@H]1CCCc2cccnc12
Molecular Formula
C21H30Cl3N5
Molecular Weight
458.86
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AZP0DOC7-HRP 100 µg/Vial
Anti-Zebrafish NPAS4L Antibody Picoband® HRP Conjugated
Sign In for Pricing
View Details 
MBS104531 Inquire
Pigeon Transient Receptor Potential Cation Channel Subfamily M, Member 7 ELISA Kit
Sign In for Pricing
View Details 
orb1593453 100 µL
Alpha smooth muscle Actin Rabbit Polyclonal Antibody (APC-Cy7)
Sign In for Pricing
View Details